How to buy Xbrane Biopharma AB (XBRANE.ST) shares | Tutorial

xbrane biopharma ab

Xbrane Biopharma AB (publ), a biotechnology company, develops, manufactures and sells biosimilars. The company is developing Xlucane, a biosimilar of ranibizumab that is in Phase III clinical trials that is used for the treatment of wet age-related macular degeneration, diabetic macular edema, diabetic-related retinopathy, and occlusion of the retinal veins. Its preclinical phase products include Xcimzane for rheumatoid arthritis, axial spondylarthrosis, psoriatic arthritis, and psoriasis and Crohn’s disease; Xoncane for acute lymphocytic leukemia; Sferotide for prostate cancer, breast cancer, endometriosis and fibroids; and Xdivane for melanoma, lung, head and throat, bladder and urinary tract cancer, as well as renal cell carcinoma. The company has a strategic biosimilar development partnership with STADA Arzneimittel AG to evaluate development and commercialization collaborations around its preclinical biosimilars Xcimzane and Xdivane. Xbrane Biopharma AB (publ) was founded in 2008 and is headquartered in Solna, Sweden.

How to buy Xbrane Biopharma AB (XBRANE.ST) shares | Tutorial

Do you want to buy shares of Xbrane Biopharma AB (XBRANE.ST) in Stockholm in Spain and through a broker with official regulation? Does it surprise you to be able to monetize your monthly benefits and earn interest on the stock market? Here I am going to show you how you can register in Degiro , a regulated investment platform with very low commissions, and how you can obtain shares of the company Xbrane Biopharma AB (publ) (XBRANE.ST) (XBRANE.ST) from quick and simple way.

The step by step is very simple :

  • First of all, we will create an account in DeGiro, an interface in which we will be able to buy shares of the company Xbrane Biopharma AB (publ) (XBRANE.ST) with the ticker (XBRANE.ST).
  • In 2nd place we will transfer €€€ to make the 1st investment in the stock market.
  • Once we see the funds in our account, we will have to locate the company Xbrane Biopharma AB looking for the ticker, which is XBRANE.ST.
  • To finish, we will go on to indicate the number of shares that we will buy, the price and the type of order.

This tutorial may have been simple for you, so now you are going to see the whole procedure with images.

How to start investing in DeGiro.

The first step is to register in Degiro through this link :

buy Xbrane Biopharma AB (publ) (XBRANE.ST) shares

It will ask us for an email, a username and a password to enter, and then we must continue with the link that they have sent us by mail.

DEGIRO will continuously ask us for important information with the interest of ascertaining that it is us . We must have on hand the passport number, DNI or driving document, your telephone number and the bank account number that we will use to make our 1st deposit. If you don’t know what this format is like, you can review this simple tutorial article that we have done at Educaceps.es .

stock Xbrane Biopharma AB

Once our account is accepted, we can enter money from the Deposit/Withdraw tab. We can carry out a transaction that will take one to two days, or proceed to make the deposit instantly with Sofort, a 100% secure and 100% reliable payment gateway.

deposit money into Xbrane Biopharma AB account

How to buy Xbrane Biopharma AB (XBRANE.ST) shares through DEGIRO

As soon as we have the capital, we can acquire our 1st share. You can select the place order button that you will find in a corner or explore in the DEGIRO search engine and put the ticker. In the next screenshot you will see that I have used the Amazon ticker but in your case you should enter (XBRANE.ST), the Xbrane Biopharma AB ticker. Since we are talking about an action, we will perceive that the related results are listed and there we will discover to find Xbrane Biopharma AB. The most important thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Xbrane Biopharma AB (publ) (XBRANE.ST) is listed in Stockholm. This step is very important so don’t get confused.

American stock market today Xbrane Biopharma AB

When developing the order we will pay close attention to the following . We have the possibility of proceeding to place a limit or market order. You think that you plan to acquire a share of Xbrane Biopharma AB, but its true price is quite prominent. With a limit order we will put the value at which we wish to execute the operation and until there are no shares for sale at that price, the purchase of the share will not be carried out. With a Degiro market order you will buy the number of shares we have suggested at today’s selling price, which would be very much in line with today’s trading price.

binance limit order Xbrane Biopharma AB (publ) (XBRANE.ST)

In all cases it is very important that you pay attention to the type of position: fixed or of the day . To serve as an example, in Spain, the stock market price is in the morning and until 1 in the afternoon, and in the United States it corresponds to the afternoon schedule in Spain. If the order is fixed, it will remain until the moment it can be executed, but if you choose the “of the day” option, at the moment the session ends, if it had not been carried out, it will be deleted from your file from Activity – Orders slopes.

I hope that this simple article has helped you to buy shares in Xbrane Biopharma AB.

  Company information
  • Address of Xbrane Biopharma AB (publ) (XBRANE.ST): Retzius väg 8 Solna 171 65 Sweden 46 7 60 34 67 33 – Website: http://www.xbrane.com
  • Ticker: XBRANE.ST
  • Sector: Health
  • Industry: Employees
  • Number of employees: 60
  • Listed market: Stockholm

key executives

Name Title Salary exercised Year of birth
Mr. Martin à ?? Mark Executive chieff. Official 1.58 million N/A 1980
Mr Siavash Bashiri Chief Operating Officer, Director of Biosimilars and Deputy General Manager 1.27 million N/A 1983
Dr Samuel Wagner Co-Founder and Member of the Scientific Advisory Board N/A N/A N/A
Mrs. Anette Lindqvist CFO and Director of Investor Relations N/A N/A 1966
Dr. David Vikström Head of Technology N/A N/A 1977
Mr. Erik Domines General Counsel N/A N/A 1964
Mrs Nina Ivers Head of human resources N/A N/A 1970
Mrs. Dinah Jurman Head of Clinical Affairs N/A N/A 1982
Ms. Maria Edebrink Head of Regulatory Affairs N/A N/A 1969
Mr. Anders Wallström Head of Manufacturing and Supply Chain N/A N/A 1976

Recent events of :

We have no recent events for this company.